Psychiatrist-Wasilla (1099)-Greenbrook

Neuronetics; Wasilla (AK); On-site; USD 250,000 - 350,000; Full time

Benefits offered by this job

No nights/on-call

Competitive compensation

TMS training

Growth in interventional psychiatry

Job summary

Greenbrook Mental Wellness Centers, a subsidiary of Neuronetics, Inc., seeks a Board Certified or Board Eligible Psychiatrist to provide onsite oversight of Transcranial Magnetic Stimulation (TMS) treatments and support the Spravato® (esketamine) program in Wasilla, Alaska.

Join a collaborative clinical and operational team offering competitive compensation, TMS certification and training, and the chance to advance interventional psychiatry while helping patients with treatment‑resistant

Qualifications

• MD or DO with current licensure in Alaska or eligibility to obtain.
• Board Certified or Board Eligible in psychiatry.
• Active Alaska medical license or ability to obtain.
• DEA registration or ability to obtain.

Responsibilities

• Provide onsite oversight of TMS treatments.
• Support the Spravato esketamine program growth.
• Collaborate with clinical and operational teams.
• Deliver high-quality psychiatric care for treatment-resistant depression.

Skills

Board Certified/Board Eligible

MD/DO

Alaska license

DEA registration

Education

MD or DO

Job description

Greenbrook Mental Wellness Centers, a subsidiary of Neuronetics, Inc., is seeking a Board Certified or Board Eligible Psychiatrist to provide onsite oversight of Transcranial Magnetic Stimulation (TMS) treatments and support the growth of our Spravato® (esketamine) program in Wasilla, Alaska.

Why Join Us?

• No nights, weekends, or on-call responsibilities
• Competitive compensation
• TMS certification and training provided
• Opportunity to expand your expertise in interventional psychiatry
• Collaborative clinical and operational support team
• Make a meaningful impact on patients with treatment-resistant depression and other mental health disorders

Qualifications

• MD or DO
• Board Certified or Board Eligible
• Active Alaska medical license (or ability to obtain)
• DEA registration (or ability to obtain)

About Greenbrook TMS

Greenbrook is a leading provider of FDA-cleared, non-invasive therapies , including TMS therapy and Spravato® , for Major Depressive Disorder and other mental health conditions. To date, Greenbrook has delivered more than 1.3 million treatments to over 40,000 patients , helping individuals reclaim their quality of life when other treatments have failed.

With over 16 million Americans affected by depression , our work matters—and so does yours.

Why Alaska?

Practice in a close-knit community while enjoying all that Alaska has to offer—stunning natural beauty, outdoor adventure, and a slower pace of life—without sacrificing professional growth or modern healthcare resources.

Applicants must be authorized to work for any employer in the US. We are unable to sponsor or assume responsibility for employment visa/work authorization at this time.

Greenbrook, a subsidiary of Neuronetics, is an equal opportunity employer that is committed to diversity and inclusion in the workplace. We prohibit discrimination and harassment of any kind based on race, color, sex, religion, sexual orientation, national origin, disability, genetic information, pregnancy or any other protected characteristic as outlined by federal, state, or local laws. This policy applies to all employment practices within our organization, including hiring, recruiting, promotion, termination, layoff, recall, leave of absence, compensation, benefits, training, and apprenticeship. Greenbrook makes hiring decisions based solely on qualifications, merit, and/or business needs at the time.

We are committed to providing equal employment opportunities to individuals with disabilities and protected veterans.

GBSP25

About Us

Neuronetics, Inc. is a leading mental health company dedicated to transforming lives through innovative treatments. Now joined with Greenbrook Mental Wellness Centers, we offer FDA-cleared NeuroStar® TMS and Spravato® therapies for major depressive disorder and treatment-resistant depression across 95+ clinics nationwide. Together, we’re expanding access to life-changing care—combining cutting-edge technology with clinical expertise to make a real impact in the mental health space.